Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Metformin/Vildagliptin (850 mg/50 mg) Film-coated Tablets Versus Galvumet®, in Healthy Subjects Under Fed Conditions.

NCT06103747 is registered in ClinicalTrials.gov with Reseach Laboratory of Clinical and Experimental Pharmacology as lead sponsor.

NCT NCT06103747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06103747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Two-way, Two-period, Single Oral Dose, Open-label, Crossover, Bioequivalence Study to Compare Metformin/Vildagliptin (850 mg/50 mg) Film-coated Tablets Versus Galvumet®, in Healthy Subjects Under Fed Conditions.
Lead sponsor
Reseach Laboratory of Clinical and Experimental Pharmacology
Phase
Phase 1
Overall status
Completed
Start date
February 21, 2023
Completion date
August 15, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fed conditions